Cite

HARVARD Citation

    Brown, M. et al. (2019). Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma. Clinical & translational immunology. 8 (5), p. n/a. [Online]. 
  
Back to record